Exor: Positive Portfolio Changes Support Continued Buy Rating

  • Exor's FY24 performance was uninspiring, with Stellantis dragging down the very strong contribution from Ferrari. Recent actions—reducing Ferrari concentration, executing a large buyback, and increasing Philips exposure—strengthen my investment case for Exor. Exor's current share price implies a discount to adjusted NAV of slightly greater than 50%, well above the historic discount level of ~30%.